Early and asymptomatic cardiac dysfunction in chronic kidney disease

Area of Science:

• Cardiology
• Nephrology
• Exercise Physiology

Background:

• Heart failure (HF) is common and deadly in chronic kidney disease (CKD).
• The mechanisms of cardiac dysfunction in CKD, particularly early on, remain unclear.
• This study investigated subclinical cardiac dysfunction in asymptomatic CKD patients without other heart issues or diabetes.

Purpose of the Study:

• To evaluate peak cardiac performance in asymptomatic CKD patients.
• To assess subclinical cardiac dysfunction in early-stage CKD.
• To compare cardiac function in CKD patients with healthy controls and HF patients.

Main Methods:

• A cross-sectional study involving 70 male non-diabetic CKD patients across different stages (2-5).
• Specialized cardiopulmonary exercise testing was used to non-invasively measure peak cardiac output and power.
• Data were compared with 35 healthy male controls and 25 male HF patients.

Main Results:

• A graded reduction in peak cardiac power was observed across CKD stages compared to controls.
• CKD patients exhibited impaired cardiac function, including reduced flow, pressure generation, chronotropic reserve, and contractility.
• The cardiac impairment in CKD mirrored that seen in heart failure patients.

Conclusions:

• This study is the first to show impaired peak cardiac performance and functional reserve in asymptomatic CKD.
• Myocardial dysfunction exists in CKD patients even without other cardiac diseases or diabetes.
• Findings necessitate further research into the pathophysiology of cardiovascular disease in CKD.